» Articles » PMID: 6687894

Immunohistologic and Immunoelectron Microscopic Characterization of the Mucosal Lymphocytes of Human Small Intestine by the Use of Monoclonal Antibodies

Overview
Journal J Immunol
Date 1983 Jun 1
PMID 6687894
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Monoclonal antibodies reactive with T cells, T cell subsets, B cells, monocytes, and natural killer cells were used to characterize the nature of mucosal lymphocytes in the human small intestine by application of the immunoperoxidase technique to tissue sections for light and electron microscopic examination. In addition, for comparison, peripheral blood mononuclear cells (PBL) were studied by immunoelectron microscopy. Most of the intraepithelial lymphocytes (IEL) were T cells (Leu-1+, T3+) and expressed the phenotype associated with cytotoxic/suppressor T cells (Leu-2a+, T8+). In contrast, a majority of T lymphocytes in the lamina propria expressed the phenotype associated with helper/inducer T cells (Leu-3a+, T4+). These observations confirm and extend the findings previously reported. In addition, a small number of cells in the lamina propria with the ultrastructural features of macrophages were found to react with anti-Leu-3a and anti-T4 antibodies. Although many IEL contained cytoplasmic granules and had ultrastructural features similar to those of circulating granular lymphocytes, none of these cells reacted with anti-Leu-7 (HNK-1), anti-T10, or anti-M1 antibodies. This suggests that IEL may not be related to circulating large granular lymphocytes, which are Leu-7+, T10+, M1+ and are associated with natural killer activity. Not only Leu-7+ PBL, but T8+, T4+, or T3+ mucosal lymphocytes or PBL also may contain cytoplasmic granules. Therefore, the cytoplasmic granules are not restricted to one cell type, in particular, to Leu-7+ cells.

Citing Articles

Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases.

Kaymak T, Hruz P, Hendrik Niess J FEBS J. 2021; 289(16):4758-4772.

PMID: 34213831 PMC: 9542113. DOI: 10.1111/febs.16103.


Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications.

Mirzaei H, Rodriguez A, Shepphird J, Brown C, Badie B Front Immunol. 2018; 8:1850.

PMID: 29312333 PMC: 5744011. DOI: 10.3389/fimmu.2017.01850.


Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.

Mirzaei H, Mirzaei H, Lee S, Hadjati J, Till B Cancer Lett. 2016; 380(2):413-423.

PMID: 27392648 PMC: 5003697. DOI: 10.1016/j.canlet.2016.07.001.


Expression of CD6 and the UCHL1-defined CD45 (p180) antigen by human colonic T lymphocytes.

Smart C, Heatley R, Trejdosiewicz L Immunology. 1989; 66(1):90-5.

PMID: 15493268 PMC: 1385125.


Evaluation of B and T lymphocytes and plasma cells in colonic mucosa from healthy dogs and from dogs with inflammatory bowel disease.

Stonehewer J, Simpson J, Else R, MacIntyre N Res Vet Sci. 1998; 65(1):59-63.

PMID: 9769074 PMC: 7172459. DOI: 10.1016/s0034-5288(98)90028-5.